BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2016
View Archived Issues
Lilly presents efficacy and safety analyses of ixekizumab for moderate-to-severe psoriasis
Read More
Novel model systems developed for adenoid cystic carcinoma of the salivary gland
Read More
Biofrontera presents full phase III results of BF-200 ALA for the treatment of BCC
Read More
Novel antifungal compound VL-2397 enters phase I trials
Read More
Cancer Genetics launches next-generation sequencing panel for solid tumors
Read More
Dana-Farber Cancer Institute and University of Pennsylvania disclose HIV entry inhibitors
Read More
Corbus to study Resunab for systemic lupus erythematosus
Read More
d-Methadone safe and well tolerated in phase I chronic pain trial
Read More
Summit Therapeutics reports microbiome data from phase II trial of ridinilazole
Read More
Enrollment opens in phase I study of ISC-hpNSC for Parkinson's disease
Read More
Celldex to discontinue phase III study of Rintega following DSMB recommendation
Read More
Serum VEGF shows promise as a prognostic marker for pemphigus foliaceus
Read More
Efficacy of CCR4 antagonist from AstraZeneca tested in canine model of atopic dermatitis
Read More
Xencor initiates phase II trials of XmAb-5871 for IgG4-related disease and SLE
Read More
Update on progress of SORAMIC liver cancer study
Read More
Cempra to receive funding for phase II/III trial of solithromycin in pediatric patients with CABP
Read More
AbbVie and Boehringer Ingelheim enter global collaboration on immunology compounds
Read More
KemPharm files IND for KP-511
Read More
One-year data from phase III trial of Cx-601 for complex perianal fistulas in Crohn's disease
Read More
Plexxikon initiates phase Ib study of PLX-51107 in advanced malignancies
Read More
ITM raises funding to advance development of radiopharmaceutical products
Read More
Companies update initiatives in light of Zika virus
Read More
